Testing effectiveness (Phase 2)Study completedNCT01300208
What this trial is testing
To Evaluate the Preliminary Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CC-11050 in Subjects With Discoid Lupus Erythematosus and Subacute Cutaneous Lupus Erythematosus
Who this might be right for
Cutaneous Lupus Erythematosus
Amgen 48